ABPI: Industry Is Getting Better at Reporting Trial Results

Drug Industry Daily
Drugmakers are getting better at reporting clinical trials results in a timely manner, with only 10 percent of studies on new treatments approved by the European Medicines Agency in 2012 not disclosed within 12 months, a new study shows.

To View This Article:


Subscribe To Drug Industry Daily